Read all posts

Why There Hasn’t Been a New Alzheimer’s Drug for 10 Years

There may be a long way to go before a new treatment for Alzheimer's comes on the market. Just three months after drug company Eli Lilly ended the clinical trial of its Alzheimer's drug solanezumab, Merck has stopped the trial of its Alzheimer's drug verubecestat because an independent study found the drug had no chance of working.

Read the article on Healthline

Dr. Sears Comments:

Dr. Barry Sears
The continuing failure in finding new drugs for Alzheimer’s is indicative of how dry the drug pipeline actually is.  Today drug companies are driven by headlines of new technologies for the future because they have few innovative technologies for the present.  Alzheimer’s is an inflammatory condition and you need anti-inflammatory drugs that can easily enter the brain to reduce neuro-inflammation.  The best known “drug” is not a drug but high fish oil.  Of course without patent protection the drug companies will touch such a “drug”, but you can.  I would recommend at least 10 grams of EPA and DHA per day.

Leave a Reply

Your email address will not be published. Required fields are marked *